Our Commitment
At Genova Biologix, safety is not a checkbox — it is the foundation on which every product is built. From the moment a donor consents to umbilical cord tissue donation through the final release of a finished product, every step in our supply chain is governed by stringent protocols designed to protect patients, support clinicians, and uphold the integrity of regenerative medicine.
Our manufacturing facility is FDA-registered and fully compliant with all applicable federal regulations. We do not cut corners. We do not compromise. Every vial that leaves our facility has been processed, tested, and validated to meet the most demanding quality standards in the industry.
Regulatory Compliance
Clinical Benefits
Our uncompromising approach to safety and quality translates directly into better outcomes for the patients you serve. When you choose Genova Biologix, you are choosing a product partner whose standards are as high as your own.
FDA Notice
Genova Biologix products are regulated under 21 C.F.R. Part 1271 and are intended for homologous use only. While produced in an FDA-compliant laboratory, they have not been approved by the FDA for treatment effectiveness.
The FDA states: "FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells for certain indications."
Patients interested in regenerative therapy should consult a physician about FDA approval status and eligibility for clinical trials.
Learn More